The chronic autoimmune conditions — both considered types of inflammatory bowel disease — cause a myriad of symptoms ...
Everyday Health on MSN
Fulminant colitis: When an ulcerative colitis flare becomes a medical emergency
ON THIS PAGESymptomsComplicationsWhy Fulminant Colitis OccursWhat to Do During a Severe UC FlareAfter a Fulminant UC EpisodeFor some people with ulcerative colitis (UC), the symptoms are mild. But for ...
EatingWell on MSN
You just got diagnosed with ulcerative colitis—here are 5 things experts say to do first
These steps can help you take control of your ulcerative colitis diagnosis.
CAMBRIDGE - Microbiotica Ltd announced on Tuesday that its oral precision microbiome medicine MB310 demonstrated positive results in a Phase 1b trial for ulcerative colitis patients, meeting primary ...
(Alliance News) - IP Group PLC on Wednesday said portfolio company Microbiotica Ltd has announced positive results from a phase 1b first-in-human trail of MB310 in ulcerative colitis patients.
Potential to become a new modality in the treatment of ulcerative colitis offering prolonged remission without immune suppressionThe study which compared MB310, a precision microbiome medicine, with ...
MB310, a live biotherapeutic developed by Cambridge-based Microbiotica, achieves 63% remission rate in early study IP Group PLC (LSE:IPO), the London-listed investor in science and technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results